# scPharmaceuticals Inc.: Form D filings

scPharmaceuticals Inc., a pharmaceuticals company in Lexington, MA, filed 5 Form D notices with the SEC between 2014 and 2017. The latest, on January 6, 2017, reports $47 million sold of a $47 million offering to 11 investors.

Find out what scPharmaceuticals Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20scPharmaceuticals%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=scPharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fscpharmaceuticals-inc-1604950)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20scPharmaceuticals%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=scPharmaceuticals%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Fscpharmaceuticals-inc-1604950)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 131 Hartwell Avenue, Suite 215, Lexington, MA, 02421
- Phone: (617) 517-0730
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Year incorporated: 2013
- Revenue range: Decline to Disclose
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1604950

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Jan 6, 2017 | New notice | $46,962,788 | $46,962,788 | $0 | 11 | Dec 22, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1604950/000160495017000001/0001604950-17-000001-index.htm) |
| Sep 6, 2016 | New notice | $10,000,000 | $4,000,000 | $6,000,000 | 3 | Aug 22, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1604950/000160495016000003/0001604950-16-000003-index.htm) |
| Sep 6, 2016 | New notice | $8,183,797 | $8,183,797 | $0 | 15 | Aug 22, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1604950/000160495016000002/0001604950-16-000002-index.htm) |
| Feb 4, 2016 | New notice | $7,500,000 | $3,600,000 | $3,900,000 | 12 | Jan 21, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1604950/000160495016000001/0001604950-16-000001-index.htm) |
| Apr 7, 2014 | New notice | $17,053,016 | $9,053,016 | $8,000,000 | 9 | Mar 24, 2014 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1604950/000160495014000001/0001604950-14-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Dorothy Coleman | Director |  |
| Abraham Ceesay | Executive Officer |  |
| Troy Ignelzi | Executive Officer |  |
| Kush Parmar | Director |  |
| Leonard Schaeffer | Director |  |
| Mette Agger | Director |  |
| Pieter Muntendam | Executive Officer, Director |  |
| Jack Khattar | Director |  |
| Abhay Gandhi | Director |  |
| Jonathan Silverstein | Director |  |

## Other pharmaceuticals companies in Massachusetts that filed recently

- [BridgeHealth Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/bridgehealth-pharmaceuticals-inc-2162724) $3.5 million · Nov 5, 2026
- [Land Therapeutics Inc.](https://specstream.ai/data/form-d/company/land-therapeutics-inc-2051104) $17.5 million · Oct 21, 2026
- [Crosslink Therapeutics Inc.](https://specstream.ai/data/form-d/company/crosslink-therapeutics-inc-2067583) $5.5 million · Oct 20, 2026
- [Sentonix, Inc.](https://specstream.ai/data/form-d/company/sentonix-inc-2039609) $12.7 million · Aug 20, 2026

[Every Form D from the week of Jan 2, 2017](https://specstream.ai/data/form-d/week/2017-01-02) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what scPharmaceuticals Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).